Lyssikatos Joseph P Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$5.04M

Insider Activity of Lyssikatos Joseph P

According to the SEC Form 4 filings, Lyssikatos Joseph P, being in a position of

  1. CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 187008 shares for $4.79M,
    over all time since 2024-01-29, has bought 0 shares, and sold 478855 shares for $11.37M.

Biography of Lyssikatos Joseph P

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $4,787,4877100

Comparison of Insiders on Amount of Buys and Sells

2026-02-06SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
5,000
0.0083%
$29.04$145,219+49.29%
2026-01-20SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
20,000
0.0333%
$26.75$535,099+58.89%
2026-01-09SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
91,198
0.1609%
$27.22$2.48M+63.58%
2026-01-08SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
41,302
0.072%
$24.05$993,436+82.65%
2025-12-19SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
5,000
0.0084%
$16.84$84,206+148.34%
2025-11-19SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
12,500
0.0213%
$22.33$279,155+87.06%
2025-11-19SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
12,008
0.0204%
$22.30$267,794+87.06%
2025-10-20SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
12,500
0.0211%
$22.08$276,025+77.8%
2025-09-26SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
4,000
0.0068%
$20.25$81,005+77.44%
2025-09-23SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
1,500
0.0026%
$20.03$30,045+75.25%
2025-09-19SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
7,000
0.0121%
$19.39$135,697+62.21%
2025-08-21SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
7,500
0.0128%
$20.01$150,099+40.78%
2025-08-19SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
5,000
0.0084%
$19.62$98,118+40.64%
2025-07-21SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
12,500
0.0216%
$22.29$278,646+18.29%
2025-06-20SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
12,500
0.0219%
$21.40$267,458+3.33%
2025-06-03SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
7,500
0.014%
$20.03$150,220-0.59%
2025-05-19SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
5,000
0.0099%
$16.31$81,534+27.89%
2025-05-02SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
2,470
0.0049%
$20.01$49,424+3.34%
2025-05-01SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
5,030
0.0104%
$20.07$100,966+6.75%
2025-04-21SaleEnliven Therapeutics, Inc.
ELVN
CHIEF SCIENTIFIC OFFICER
5,000
0.0092%
$16.07$80,366+27.81%
Total: 37
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.